The Community Forum creates a space for the PHUSE Community to unite and discuss industry topics of interest in an informal setting. Alongside this, each Working Group will use Disqus to host offline discussions and continue sharing information. |
This event is free and |
takes place virtually |
. If you have any questions |
, contact workinggroups@phuse.global. |
Safety Analytics: Reimagining a Safety Submission – Vision of Interactive Safety Reviews – 27 March 2023
During this forum, you’ll hear about various efforts related to interactive safety reviews. This will then be followed by a discussion on the end goal, potential impact on submissions, and different models for creating and sharing interactive safety review tools. Register here!
Data Transparency: Data Privacy and Data Sharing in Clinical Trials – 21 February 2023
Data Transparency Working Group lead, Devaki Thavarajah, is the host of the Working Group’s first Community Forum. The Educate the General Population project have recently published two out of a series of six videos on Data Sharing in Clinical Trials and are calling for your feedback!
To catch up on the previous Community Forums, visit the PHUSE archive. |
Previous Community Forums:
| Date/ Time | Working Group | Title | Speakers | Recordings |
|---|---|---|---|---|
18 January | Real World Evidence | Dr Cheryl Grandinetti, FDA andKris Wenzel, MMS | Recording | |
21 February | Vera Pomerantseva, ZS Associates | Recording | ||
17 April | Dr. Junshui Ma, Merck | Recording | ||
18 April | Michèle Arnoe, IQVIA, Jeffrey Brown, TriNetX andBenjamin Forred, Sanford Research | Recording |
In this Community Forum, PHUSE Safety Analytics Working Group Leads, Mary Nilsson and Greg Ball, as well as Barbara Hendrickson and Robert Gordon, introduced two new FDA premarket safety analytics documents. A discussion took place on how past and current efforts from cross-industry Working Groups can be leveraged to prepare the ecosystem for operationalising them. Join the post meeting discussion by sharing your comments on the Disqus Forum.